Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04415983

Study of Nitazoxanide (NTZ) for Helicobacter Pylori in Children

Study of Nitazoxanide (NTZ) based therapeutic regimens for Helicobacter pylori in children

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Helicobacter Pylori Infection

Age range

Up to 18 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

About this study

Study of Novel triple Nitazoxanide (NTZ) based new therapeutic regimens for Helicobacter pylori in children

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Positive helicobacter infection.

Exclusion criteria

  • Previous treatment for H. Pylori.

Treatment and study plan

Nitazoxanide

Drug

Nitazoxanide twice daily

Other names: nanazoxid

Clarithromycin

Drug

Klacid twice daily

Other names: Klacid

Metronidazole

Drug

Metronidazole twice daily

Other names: Flagyl

Proton Pump Inhibitor

Drug

Omeprazoe twice daily

Primary outcomes

  1. Number of patients with cured helicobacter infection

    Time frame: 6 months

    Total number of patients with eradicated helicobacter infection

Study contacts

Contact information is provided by the study sponsor or research team.

Sherief Abd-Elsalam, ass. prof.

CONTACT

[email protected]

00201147773440

Sponsors and collaborators

Lead sponsor

Tanta University

Other

Registry information

Official study title

Study of Novel Triple Nitazoxanide (NTZ) Based New Therapeutic Regimens for Helicobacter Pylori in Children

Important dates

Study start
2020
Primary completion
2030
Study completion
2030
First posted
Jun 4, 2020
Registry last updated
Jun 4, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.